Rob Verhoeven

16PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)MigrationEpidemiological methodsSolid tumoursMulticultural education (excl. Aboriginal and Torres Strait Islander, Māori and Pacific Peoples)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 08, 2026
Second-line oxaliplatin reintroduction or paclitaxel-ramucirumab in metastatic gastroesophageal cancer: a population-based study.

|Sep 23, 2025
Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival.

Rob H A Verhoeven, Steven C Kuijper, Marije Slingerland

|Nov 11, 2024
Gastric Cancer Risk among Immigrants and Socioeconomic Groups in the Netherlands.

Duco T Mülder, Hilliene J van de Schootbrugge-Vandermeer, James F O'Mahony

|Mar 27, 2023
Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study.

Marieke Pape, Pauline A J Vissers, Willemieke P M Dijksterhuis

|Aug 23, 2022
Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer.

Marieke Pape, Pauline A J Vissers, David Bertwistle

|Jun 27, 2022
Preparing tomorrow's medical specialists for participating in oncological multidisciplinary team meetings: perceived barriers, facilitators and training needs.

Janneke E W Walraven, Renske van der Meulen, Jacobus J M van der Hoeven

Pageof 3

Frequent Collaborators

5 joint publications

Héctor G van den Boorn

3 joint publications

Mark I van Berge Henegouwen

2 joint publications

Ameen Abu-Hanna

2 joint publications

Pauline A J Vissers